Difference in efficacy of the Cell Saver in coronary bypass grafting surgery and cardiac valvular reoperations.

M. J. Wang, Ta-Liang Chen, C. H. Huang, A. Chao, S. H. Chu

研究成果: 雜誌貢獻文章同行評審

2 引文 斯高帕斯(Scopus)

摘要

The efficacy of the Cell Saver in reducing transfusion requirements in patients who underwent either coronary artery bypass grafting (CABG) or reoperation for valvular replacement (Redo) were prospectively studied in 112 patients. In 41 patients, the Cell Saver was used from the beginning of the surgery (group 1), and in the other patients, no blood conservation techniques were undertaken (group 2). Perioperative hematological profile, postoperative chest tube drainage and transfusion requirements were examined in all patients. More red cells could be retrieved from the Redo patients than from the CABG patients (p <0.05) during operation. The use of the Cell Saver in CABG patients reduced the total amount of blood transfusion required (p <0.001). However, in the Redo patients, the use of the Cell Saver did not reduce the transfusion requirements during hospitalization. Furthermore, the amount of platelet concentrates transfused in the group 1 Redo patients was greater than the group 2 Redo patients. The use of the Cell Saver did not increase the postoperative chest tube drainage in either the CABG or the Redo patients. We conclude that the Cell Saver is useful in CABG patients, as far as the reduction of transfusion requirements is concerned; however, its efficacy in reducing transfusion requirements for Redo patients is questionable.

原文英語
頁(從 - 到)117-121
頁數5
期刊Journal of the Formosan Medical Association = Taiwan yi zhi
93
發行號2
出版狀態已發佈 - 二月 1994
對外發佈Yes

ASJC Scopus subject areas

  • Medicine(all)

指紋 深入研究「Difference in efficacy of the Cell Saver in coronary bypass grafting surgery and cardiac valvular reoperations.」主題。共同形成了獨特的指紋。

引用此